DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 53 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $514,000 | -56.5% | 25,509 | -19.5% | 0.00% | -66.7% |
Q2 2021 | $1,182,000 | +63.9% | 31,680 | +12.4% | 0.00% | +50.0% |
Q1 2021 | $721,000 | +25.0% | 28,183 | +7.6% | 0.00% | 0.0% |
Q4 2020 | $577,000 | +60.7% | 26,194 | +31.2% | 0.00% | 0.0% |
Q3 2020 | $359,000 | -31.5% | 19,962 | -3.3% | 0.00% | -33.3% |
Q2 2020 | $524,000 | +127.8% | 20,641 | +64.5% | 0.00% | +50.0% |
Q1 2020 | $230,000 | -52.2% | 12,547 | -42.5% | 0.00% | 0.0% |
Q4 2019 | $481,000 | +37.4% | 21,817 | -10.6% | 0.00% | 0.0% |
Q3 2019 | $350,000 | -13.4% | 24,406 | -4.9% | 0.00% | 0.0% |
Q2 2019 | $404,000 | +1.5% | 25,673 | -5.5% | 0.00% | 0.0% |
Q1 2019 | $398,000 | +38.2% | 27,156 | +0.9% | 0.00% | 0.0% |
Q4 2018 | $288,000 | +274.0% | 26,927 | +105.7% | 0.00% | +100.0% |
Q3 2016 | $77,000 | +67.4% | 13,089 | -15.2% | 0.00% | 0.0% |
Q2 2016 | $46,000 | -49.5% | 15,428 | -9.2% | 0.00% | 0.0% |
Q1 2016 | $91,000 | -59.2% | 16,983 | -9.5% | 0.00% | -66.7% |
Q4 2015 | $223,000 | – | 18,760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |